VANCOUVER, British Columbia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") will file its First Fiscal Quarter financial reports after TSX.V market close on Thursday, Feb 9, 2023 (prior to ASX market open on Friday, Feb 10, 2023).
Fiscal Q1 2023 Conference Call Details
Euro Manganese will host two separate conference calls to serve stakeholders in their respective time zones. Content of both calls will be the same.
Calls will be hosted on Zoom, with the ability to dial-in or join via web link. Questions may be asked directly or using the chat function. Replays and transcripts of both calls will be available on Euro Manganese's website: www.mn25.ca
|CALL #1 ? For North American and UK/European Audiences|
|Date||Monday, Feb 13, 2023||Monday, Feb 13, 2023|
|Time||8:30am PST | 11:30am EST||4:30pm GMT | 5:30pm CET|
|CALL #2 ? For Australian Audiences|
|Date||Tuesday, Feb 14, 2023||Monday, Feb 13, 2023|
|Time||6:00am AWST | 9:00am AEDT||2:00pm PST | 5:00pm EST|
About Euro Manganese
Euro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and exploring an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.
The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.
Euro Manganese is dual-listed on the TSX.V and the ASX, and is also traded on the OTCQX.
Authorized for release by the CEO of Euro Manganese Inc.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the ASX accepts responsibility for the adequacy or accuracy of this release.
Dr. Matthew James
President & CEO
+44 (0)747 229 6688
Senior Director, Investor Relations & Communications
+1 (604) 312-7546
Company Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8
These press releases may also interest you